
Top
20 pharmaceutical firm
Major primary care product facing patent expiration Limited
primary care pipeline
Management
strategy: grow primary care sales force size through in-licensing

Analyzed
primary care sales team sizing
Expiring product could not support continued promotion except
under most optimistic scenarios
In-licensing unlikely to provide margin necessary to profitably
sustain current team sizes
Analyzed
specialty care sales teams
Highly profitable
Under-resourced
Recommended
Downsize retail teams
Decline unprofitable co-promotion opportunities
Establish two new specialty teams to increase frequency on
key customers

Profits
increased 20% with a 10% reduction in sales force investment
according to client estimates
|